Role and Mechanism of Microglia in White Matter Injury Recovery in Ischemic Stroke

Yi-Sha Guo1, Yunlin Shang1, Jiajia Yao1

  • 1Department of Physical Therapy, Affiliated Yangzhi Rehabilitation Hospital of Tongji University, Shanghai Yangzhi Rehabilitation Hospital, Shanghai, China.

PubMed
Abstract

Insights

Microglia play a dual role in white matter injury following ischemic stroke, with distinct activation states influencing damage and repair. Understanding these dynamics is key to developing targeted therapies for neurological recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Neuropathology

Background:

  • Ischemic stroke often causes white matter injury (WMI), impairing neurological function.
  • Microglia, the brain's immune cells, have a complex role in post-stroke WMI and recovery.
  • Their activation states and glial interactions affect myelin damage and repair.

Purpose of the Study:

  • To systematically review and synthesize evidence on microglia's temporal and functional roles in ischemic stroke-induced WMI.
  • To focus on microglia's specific contributions to white matter damage and subsequent recovery.

Main Methods:

  • Comprehensive literature search of PubMed, Web of Science, and Scopus databases (up to Dec 2024).
  • Keywords: "ischemic stroke," "white matter injury," "microglia," "myelin," "oligodendrocytes."
  • Prioritized studies on microglial polarization, myelin repair, and molecular pathways; included preclinical and clinical research.

Main Results:

  • Microglia show distinct profiles in acute (pro-inflammatory, exacerbating WMI) and chronic (immune-regulatory, promoting remyelination) phases.
  • Key pathways like TREM2, CX3CR1, and purinergic signaling regulate microglial function.
  • Therapeutic strategies targeting microglial phenotypes show potential for enhancing white matter repair.

Conclusions:

  • Microglia's effects on WMI post-stroke are time- and region-specific.
  • Understanding dynamic microglial phenotypes and glial interactions is crucial for targeted therapies.
  • Future research needs single-cell tech, human validation, and sex-specific analysis for refined interventions.